Latest Grifols Inc. Stories
- Representing over a $370 million capital investment, the new 155,000 square-foot facility will be host to 200+ employees, one of the largest capital projects in Johnston County, NC history and will
RESEARCH TRIANGLE PARK, N.C., June 8, 2011 /PRNewswire/ -- (NASDAQ: GRFS) - Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain, today announced that it has officially begun to merge its operations with Talecris Biotherapeutics in order to function as one company, following its acquisition of Talecris on June 1.
BARCELONA, Spain, Feb.
LOS ANGELES, Feb. 3, 2011 /PRNewswire/ -- Grifols, Inc. today announced that it has expanded the company's PatientCare Program to offer immune globulins (IVIG) to the Primary Immune Deficiency community (PID).
BARCELONA, June 24 /PRNewswire/ -- Spanish biotechnology company Progenika Biopharma, specializing in the development of personal medicine technology, has granted Grifols exclusive world-wide distribution rights for its BLOODCHIPÂ® molecular biology products.
- A trick or prank.